Zacks.com featured highlights include LyondellBasell, Star Bulk, Cenovus and Nexa Resources

Zacks highlights four high earnings-yield value stocks—LYB, SBLK, CVE and NEXA—with 2026 EPS growth estimates of 414%, 313%, 105% and 214%, respectively. All four carry Zacks Rank #1, with Value Scores of A for LYB, SBLK and NEXA, and B for CVE. The article is broadly constructive on their fundamentals, cash generation and shareholder-return profiles, but it is primarily a screening piece and likely to have limited immediate price impact.

Analysis

The common thread here is not “value” so much as cyclicals with self-help and balance-sheet distribution stories that are being repriced off depressed sentiment. That combination tends to work best when estimates are being revised up faster than the macro backdrop is deteriorating, because the market pays twice: first for multiple compression unwinding, then for forward cash-flow visibility. The near-term risk is that these screens are backward-looking if commodity prices or freight rates mean-revert before the operating leverage shows up in reported numbers.

LYB is the cleanest capital-return story, but also the most exposed to a late-cycle squeeze in spread compression and inventory destocking. If energy input costs stay benign while product prices hold, the free-cash-flow torque is meaningful; if not, buybacks become the shock absorber rather than the driver. CVE is more interesting than a plain beta-to-oil name because downstream earnings can cushion crude volatility, making it a better hold through a choppy macro tape than pure upstream peers.

SBLK and NEXA are the higher-beta expressions of the same theme and likely offer the most upside if global growth stabilizes, but they also have the sharpest drawdowns if China-related demand or iron/steel-linked freight weakens. The market is underestimating how quickly rate cuts in shipping or metals price pullbacks can erase consensus revisions, so these are best treated as tactical trades, not core longs. The contrarian angle is that the best risk-adjusted setup may be the least glamorous: companies with modest upside but explicit cash returns, rather than those with the highest headline earnings yield.

Second-order, a sustained bid in these cyclicals can tighten competition for capital across adjacent low-multiple names, forcing weaker peers to defend dividends or cut maintenance capex. That usually creates a delayed spread trade in which the strongest balance sheets outperform for months while weaker operators lag as financing costs remain sticky. The main reversal catalyst is not a single earnings miss but a sequence: lower commodity prices, downward estimate revisions, and management becoming less aggressive on capital returns within 1-2 quarters.

Key Decisions for Investors

• Long LYB vs short a basket of higher-cost chemical peers for 3-6 months; best if spreads stay stable and buyback cadence remains intact. Risk/reward favors the long leg as long as estimate revisions keep trending up.
• Trade CVE as the highest-quality cyclicals hold: accumulate on pullbacks over the next 2-8 weeks, with a 6-12 month horizon. Downside is cushioned relative to pure upstream names if crude softens.
• Use SBLK as a tactical momentum/value hybrid: initiate only on freight-rate confirmation, then trail stops tightly over 1-3 months. Upside can be sharp, but the thesis breaks quickly if ton-mile demand stalls.
• Treat NEXA as a high-beta commodity call rather than a durable compounder; prefer call spreads or a smaller cash equity position over the next 1-2 quarters. If zinc and silver prices roll over, earnings leverage will reverse faster than consensus can adjust.
• Avoid chasing the full basket equally; overweight the names with explicit capital-return support (LYB, CVE) and underweight the most economically sensitive names (SBLK, NEXA) unless macro data turns decisively better.